Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo. | J Cell Mol Med | 2024 | 38520207 | PubTator, text mining | PubMed |
| Skeletal stem cells in bone development, homeostasis, and disease. | Protein Cell | 2024 | 38442300 | PubTator, text mining | PubMed |
| Evaluation of endometrial receptivity in recurrent pregnancy loss and recurrent implantation failure. | Turk J Obstet Gynecol | 2024 | 38440964 | PubTator, text mining | PubMed |
Statement of Retraction: Long non-coding RNA HOXA11 antisense RNA upregulates spermatogenesis-associated serine-rich 2-like to enhance cisplatin resistance in laryngeal squamous cell carcinoma by suppressing microRNA-518a. | Bioengineered | 2024 | 38376870 | PubTator, text mining | PubMed |
| Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. | Clin Exp Med | 2024 | 38294554 | PubTator, text mining | PubMed |
| Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review. | Medicine (Baltimore) | 2024 | 38277554 | PubTator, text mining | PubMed |
| [Corrigendum] Propofol‑induced HOXA11‑AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‑4458. | Int J Mol Med | 2024 | 38275122 | PubTator, text mining | PubMed |
| ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers. | Cancer Manag Res | 2024 | 38259608 | PubTator, text mining | PubMed |
| HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation. | Heliyon | 2024 | 38192826 | PubTator, text mining | PubMed |
| Emerging role of lncRNAs in the etiology of recurrent implantation failure. | Pathol Res Pract | 2024 | 38147725 | PubTator, text mining | PubMed |
| A human embryonic limb cell atlas resolved in space and time. | Nature | 2024 | 38057666 | PubTator, text mining | PubMed |
| Global Transcriptome Analysis Reveals Distinct Phases of the Endothelial Response to TNF. | J Immunol | 2024 | 38019121 | PubTator, text mining | PubMed |
| LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity. | Cancer Commun (Lond) | 2024 | 38010289 | PubTator, text mining | PubMed |
| Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer. | Oncogene | 2024 | 37989866 | PubTator, text mining | PubMed |
| SINE-Associated LncRNA SAWPA Regulates Porcine Zygotic Genome Activation. | Adv Sci (Weinh) | 2024 | 37984872 | PubTator, text mining | PubMed |
| lncRNA HOTAIRM1 Activated by HOXA4 Drives HUVEC Proliferation Through Direct Interaction with Protein Partner HSPA5. | Inflammation | 2024 | 37898994 | PubTator, text mining | PubMed |
| Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword. | Genes Dis | 2024 | 37588204 | PubTator, text mining | PubMed |
| NUP98 rearrangements in AML: molecular mechanisms and clinical implications. | Onco (Basel) | 2023 | 42164049 | PubTator, text mining | PubMed |
| High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data. | Front Physiol | 2023 | 38304289 | PubTator, text mining | PubMed |
| Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies. | Front Cell Neurosci | 2023 | 38249528 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=4